Harriet E. Feilotter
Toronto, ON M5G2C4, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
Assessing the Clinical Relevance of BRCA1 RING Domain Variants of Uncertain Significance.
Journal: Current oncology (Toronto, Ont.)
Published: April 28, 2026
Domain-Specific Computational, Functional and Structural Methods Enable Interpretation of BRCA1 BRCT Variants of Uncertain Significance.
Journal: Current oncology (Toronto, Ont.)
Published: April 17, 2026
Panel of Methylation-based PCRs for Separating Mucinous Lung Adenocarcinomas from Gastrointestinal Metastases Involving the Lung.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: January 12, 2026
Evaluating the Utility and Implementation Barriers of a Liquid Biopsy Biomarker Test Early in the Lung Cancer Diagnostic Pathway to Improve Timeliness of Palliative Systemic Therapy.
Journal: Current oncology (Toronto, Ont.)
Published: November 27, 2025
Reply to "Methylation-based droplet digital polymerase chain reaction shows high concordance with chronic lymphocytic leukemia IGHV somatic mutation status".
Journal: American journal of clinical pathology
Published: September 21, 2025
The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary: A Systematic Review.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: June 11, 2025
Multiplex PCR for the Rapid Diagnosis of Myeloproliferative Neoplasms.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: April 14, 2025
Methylation-based droplet digital polymerase chain reaction shows high concordance with chronic lymphocytic leukemia IGHV somatic mutation status.
Journal: American journal of clinical pathology
Published: January 26, 2025
Downregulation of the Unfolded Protein Response Links Metformin Treatment to Good Clinical Outcomes in Colorectal Cancer Patients.
Journal: Current oncology (Toronto, Ont.)
Published: January 20, 2025
Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is Transient.
Journal: JCO precision oncology
Published: August 23, 2024
Guidance for securing approvals for new biomarkers: from discovery to clinical implementation.
Journal: Critical reviews in clinical laboratory sciences
Published: July 31, 2024
Last Updated: 09/26/2026